DASARAJU, R. (2023) “AUDIT OF USFDA APPROVALS FOR 2022 FROM THE PERSPECTIVE OF INNOVATION”, Asian Journal of Pharmaceutical and Clinical Research, 16(7), pp. 53–57. doi: 10.22159/ajpcr.2023.v16i7.47509.